home | about us | attorneys | actos | bladder cancer | faqs | articles | law resources | press release | contact us | blog | Log in
Copyright ©2007-2010 Williams Kherkher. Attorneys are licensed only in the state of Texas unless otherwise indicated in the biographical section. Past performance is no guarantee of future results. Williams Kherkher's primary office is located in Texas. Terms of Use. Disclaimer. Sitemap.
8441 Gulf Freeway, Suite 600, Houston, TX 77017-5051 -- 800-641-9810 | John Eddie Williams +
Consumer Reports urges consumers to avoid Actos
Posted on September 10th, 2012
No Comments
Days after the Food and Drug Administration’s (FDA) approval of a generic version of Actos (pioglitazone), consumer advocacy group Consumer Reports released a statement claiming that the risks of using pioglitazone far outweigh its benefits. The group asks customers to avoid Actos and its generics unless other treatments have failed them, citing the drug’s dangerous [...]
Study finds bladder cancer risk from Actos higher than originally predicted
Posted on June 6th, 2012
No Comments
A new study published by British Medical Journal has shown the bladder cancer risk associated with Actos is much higher than previously anticipated. When major concerns about the drug’s relation to bladder cancer arose last June, scientists estimated that Actos increased patients’ risks of developing the illness by 40%. The new study places that figure [...]
Takeda Pharmaceutical prepares for Actos patent to expire
Posted on May 16th, 2012
No Comments
As Takeda Pharmaceutical’s patent on Actos gets closer to its August expiration, the company is making efforts to offset the decreased profits it will lose to generic versions of the drug. The company expects to miss out on over $2 billion in revenue to generic versions of its flagship drug. Takeda has been preparing for [...]
Increased use of Actos in treating depression may lead to more cases of bladder cancer
Posted on May 11th, 2012
No Comments
The journal Neuropsychopharmacology has published a study that shows Actos may be useful in treating depression. The study, conducted by researchers at Tehran University, shows that Actos might help boost the effects of antidepressant drugs in treating major depressive disorders. The study found that patients who took Actos alongside their antidepressants reported more symptom relief. [...]
Actos replacement denied by FDA
Posted on May 1st, 2012
No Comments
While Actos is being plagued by its link to numerous life-threatening ailments, its heir may be facing guilt by association. Takeda Pharmaceutical’s patent on pioglitazone (the active ingredient in Actos) is due to run out this August. The company will soon be facing competition from generic pioglitazone manufacturers. Because of this, the company is hoping [...]
Takeda may face more than 10,000 Actos lawsuits
Posted on March 19th, 2012
No Comments
The largest drugmaker in Asia, Takeda Pharmaceuticals, may now face nearly 10,000 lawsuits over the Type 2 diabetes medication, Actos. The cases were consolidated in December and the first hearings are set to be heard in March. These lawsuits claim that Actos increased their risk of developing bladder cancer when used for over a year. [...]
Actos: Whistleblower in case alleges officials hid bladder cancer risks
Posted on March 12th, 2012
No Comments
A U.S. District Judge has recently made the order to unseal a whistleblower case of the former medical reviewer for Takeda Pharmaceuticals involving the failure to report bladder cancer risks from the use of the popular Type 2 diabetes medication, Actos. The whistleblower is a doctor and former safety reviewer for Takeda who worked to [...]
Diets vary for those with Type 2 diabetes
Posted on February 13th, 2012
No Comments
For people suffering from Type 2 diabetes, there is no perfect diet that will work for everyone and the best idea is to find out what will work for you. Some people who suffer from type 2 diabetes work well with low-carb diets while others do best on low-fat diets. A common factor that has [...]
Lawsuits against Actos are expected to reach over a thousand
Posted on January 30th, 2012
No Comments
Lawsuits against Actos, a type 2 diabetes medication, claim that the use of this drug for over a year has caused bladder cancer. Officials close to this case have stated that the number of lawsuits in this case are expected to reach in the thousands and the lawsuits have now been centralized in the Western [...]
Low profits cause Takeda to cut back on workforce
Posted on January 18th, 2012
No Comments
Takeda Pharmaceuticals has stated that they will be cutting nine percent of their workforce in order to make up for an 11-year low in profits. The company will be cutting 2,800 jobs over a four year period and this will take place mainly in the U.S. and Europe. The drug maker is hoping that the [...]
By submitting this form, you certify that you agree to our terms and conditions and wish to be contacted regarding your inquiry.
Archives
- April 2013
- February 2013
- January 2013
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
Categories
- Actos and bladder cancer lawyers (17)
- Actos attorneys (12)
- Actos bladder cancer attorneys (9)
- Actos bladder cancer lawsuit attorneys (9)
- Actos bladder cancer lawsuit lawyers (16)
- Actos bladder cancer lawyers (25)
- Actos lawsuit attorneys (26)
- Actos lawsuit lawyers (24)
- Actos lawyers (8)
- Actos mass tort attorneys (2)
- Actos side effects lawyers (3)
- Bladder Cancer and Actos (1)
- bladder cancer symptoms lawyers (4)
- bladder cancer treatments (1)
- Diabetes drug side effect (3)
- Risk of diabetes (1)
- Takeda Pharmaceuticals (4)
- Uncategorized (1)
Blogroll
- Accutane Lawsuit Attorney
- Depakote Lawyers
- Depuy Lawsuit Attorney
- Mesothelioma Lawyers
- Reglan Lawsuit Attorney
- Topamax Lawsuit Attorney